NCT06798675View on ClinicalTrials.gov

Phase 2a Study for PK/PD of nC-001

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
CHRONIC HYPONATREMIA
Interventions
DRUG

nC-001

solid dosage form single dose

DRUG

Placebo

Placebo

All Listed Sponsors
lead

nephCentric

INDUSTRY